NYSE - Delayed Quote USD

ResMed Inc. (RMD)

218.57 -1.40 (-0.64%)
At close: May 17 at 4:00 PM EDT
219.80 +1.23 (+0.56%)
After hours: May 17 at 6:00 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Michael J. Farrell BE, MBA, SM CEO & Chairman 2.87M 11.2M 1972
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD Founder, Chair Emeritus & Director 430.21k -- 1942
Mr. Brett A. Sandercock Chief Financial Officer 909.64k 1.79M 1967
Mr. Robert A. Douglas Special Advisor 1.91M 8.98M 1960
Mr. Kaushik Ghoshal Chief Commercial Officer - SaaS 1.11M -- 1969
Ms. Amy Wakeham Chief Investor Relations Officer -- -- --
Mr. Michael J. Rider Chief Legal Officer -- -- 1958
Mr. Jim Ellis Chief Compliance Officer -- -- --
Ms. Yvonne-Katrin Pucknat Chief Marketing Officer -- -- --
Ms. Vered Keisar Chief People Officer -- -- --

ResMed Inc.

9001 Spectrum Center Boulevard
San Diego, CA 92123
United States
858-836-5000 https://www.resmed.com
Sector: 
Healthcare

Description

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.

Corporate Governance

ResMed Inc.’s ISS Governance QualityScore as of May 1, 2024 is 4. The pillar scores are Audit: 1; Board: 8; Shareholder Rights: 3; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

June 13, 2024 at 12:00 AM UTC

Dividend Date

August 1, 2024 at 10:59 AM UTC - August 5, 2024 at 12:00 PM UTC

ResMed Inc. Earnings Date

Recent Events

May 14, 2024 at 8:05 PM UTC

at RBC Capital Markets Global Healthcare Conference

May 8, 2024 at 12:00 AM UTC

Ex-Dividend Date

April 26, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 25, 2024 at 8:30 PM UTC

Q3 2024 Earnings Call

April 25, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 25, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

January 24, 2024 at 9:30 PM UTC

Q2 2024 Earnings Call

January 24, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 20, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 9, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers